CMON Acquires Zombicide Franchise From Guillotine Games

CMON Limited announced today that it has acquired all branding and intellectual property rights for the successful Zombicide franchise from Guillotine Games. Guillotine Games will continue to work exclusively with CMON to bring fans new, exciting titles, all with the quality they’ve come to expect from both companies. David Preti, Director of Guillotine Games, will also become Creative Director of CMON Limited and says, “I’m pleased to see Zombicide in the hands of CMON, and I’m excited for my new role in the company while continuing to bring new, great Guillotine Games titles to gamers.”

Zombicide is a cooperative board game with high-quality miniatures for 1 to 6 players. Players choose their survivors of a zombie apocalypse, find weapons, slay zombies, gain experience and customize their heroes as the game progress. However, the more zombies they kill, the more powerful the undead become. Survivors must work together to complete the mission against the intuitive zombie AI or die trying.

Zombicide was first introduced to the world through the crowd-funding site Kickstarter, and the franchise has since raised over $10 million on the platform. The franchise currently includes Zombicide Season 1, Zombicide Season 2: Prison Outbreak, Zombicide Season 3: Rue Morgue, Zombicide: Black Plague, and multiple expansions. In total, it has sold tens of thousands of units through retail stores and Kickstarter.

Player Support

Need Assistance? Click here to reach our dedicated Customer Support team for help with your order, address changes, refunds, or parts replacements.

Subscribe to our newsletter!

Email

Marketing Permissions

By clicking the button below, you will sign up to CMON's newsletter. We will contact you via email to market our own products, products from our partners or news items that we believe you may be interested in.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at [email protected]. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.